Previous 10 | Next 10 |
naphtalina/iStock via Getty Images COVID-19-related headlines dominated the holiday-shortened week as the Delta variant of the virus renewed pandemic fears across the globe. Meanwhile, with a ~1.3% gain over the past five-day period, the S&P 500 Healthcare Index outper...
7 Penny Stocks on Reddit to Add to Your Watchlist Finding the best penny stocks on Reddit can be a great way to stay ahead. But, just certain penny stocks are trending, does not mean that they are worth investing in. Rather, investors need to do the proper due diligence to understan...
Andrii Yalanskyi/iStock via Getty Images H.C. Wainwright is sticking by Iterum Therapuetics ([[ITRM]] -8.1%) and maintaining a buy rating on the stock even though shares plunged on Friday after the FDA told the company there were deficiencies in the company's NDA for the antibiotic sulopenem ...
Iterum looked to be on track for a July 25 PDUFA for its first commercial drug, sulopenem. Now, the company faces uncertainty as the FDA has issued a letter seeking labeling clarification. After climbing 150% in a short time, shares collapsed back under $2. Opportunistic inves...
Gainers: Sequential Brands Group (SQBG) +88%.Alector (ALEC) +50%.TAT Technologies (TATT) +43%.Marin Software (MRIN) +41%.Overseas Shipholding (OSG) +35%.Staffing 360 Solutions (STAF) +31%.Bridgeline Digital (BLIN) +31%.IDT (IDT) +21%.Nortech Systems (NSYS) +19%.Ocean Power Technologies (OPTT)...
Shares of Iterum Therapeutics (NASDAQ: ITRM) had crashed 35.5% as of 11:08 a.m. EDT on Friday. The big decline came after the company announced after the market close on Thursday that it had received a letter from the Food and Drug Administration (FDA). This letter, the company said...
Gainers: Alector (ALEC) +69%. Lucira Health (LHDX) +9%. Provention Bio (PRVB) +7%.Losers: Iterum Therapeutics (ITRM) -34%. Arrowhead Pharmaceuticals (ARWR) -26%. Alterity Therapeutics (ATHE) -21%. Citius Pharmaceuticals (CTXR) -20%. TRxADE HEALTH (MEDS) -17%. For fu...
Virgin Galactic (SPCE) has taken off again in Friday's pre-market, as the company takes definitive steps toward a July 11 launch that will take billionaire founder Richard Branson into space. This comes amid worries on Wall Street about the space tourism company's valuation.Meanwhile, another...
Iterum Therapeutics (ITRM) -41% after FDA identifies deficiencies in sulopenem NDA.Arrowhead Pharmaceuticals (ARWR) -23% after pausing mid-stage AROENaC1001 study in cystic fibrosis.Birks Group (BGI) -13%.Alterity Therapeutics (ATHE) -12%.Kintara Therapeutics (KTRA) -8%.Ci...
Iterum Therapeutics (ITRM) plummets 40% in after-hours trading after receiving FDA notification regarding NDA for sulopenem etzadroxil/probenecid.The letter stated that, as part of the ongoing review, the Agency has identified deficiencies that preclude the continuation of the discussion...
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Iterum Therapeutics plc Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
DUBLIN, Ireland and CHICAGO, June 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
DUBLIN and CHICAGO, June 05, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hosp...